Upadacitinib for treating moderately to severely active ulcerative colitis

Equality Impact Assessment (Guidance development) (PDF 157 KB)

Final draft guidance

Final appraisal document (PDF 200 KB)

Committee papers (PDF 8.07 MB)

Public committee slides (PDF 2.22 MB)

Final scope (PDF 204 KB)

Final stakeholder list (PDF 157 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 316 KB)

Equality impact assessment (Scoping) (PDF 133 KB)

Draft scope post referral (PDF 237 KB)

Draft matrix post referral (PDF 156 KB)